In the decision reported last week of the Competition Commission of India (CCI) taking a majority view that there is cartelization by incumbents Vodafone, Airtel and Idea in the telecom sector, two of its members believe there is no such case.
The interim CCI order had directed a detailed probe in this regard by its director-general against the major incumbents for allegedly trying to block the entry of Reliance Jio into the segment.
However, the two members have said Reliance Jio is to blame, not the others. Economic Times has reviewed the order, and the two members have said Jio’s complaint is not justified. The reasoning is that Jio is still in its trial phase, not marketing the product commercially. and, as Jio’s users aren’t being charged for the period under review, they are not subscribers.
They have noted test cards “are to be issued to business associates, employees, relations, etc., only for the purpose of checking the quality of service. This does not seem to be the case with R-Jio. Thus, the alleged non-provisioning of demand of POIs (points of interconnections) by the telecom operators or reasonability of demand needs to be seen in this light.”
Full Content: Economic Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas